Article Details

Jemincare, Roche ink $650 M deal for prostate cancer treatment - BioSpectrum Asia

Retrieved on: 2022-08-18 10:14:39

Tags for this article:

Click the tags to see associated articles and topics

Jemincare, Roche ink $650 M deal for prostate cancer treatment - BioSpectrum Asia. View article details on hiswai:

Excerpt

Jemincare, a leading pharmaceutical company from China, has entered into an exclusive worldwide license agreement with Roche and Genentech, ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up